Literature DB >> 22341412

Bother problems in prostate cancer patients after curative treatment.

Andreas Stensvold1, Alv A Dahl, Bjørn Brennhovd, Milada Cvancarova Småstuen, Sophie D Fosså, Wolfgang Lilleby, Andreas Steinsvik, Karol Axcrona, Sigbjørn Smeland.   

Abstract

BACKGROUND: Most previous studies of prostate cancer (CaP) patients have focused on functional side effects. In the decision about treatment, the patients' subjective experience of function (bother) should also be considered. In this prospective study of CaP patients, we used both categorical and dimensional methods to examine changes of sexual, urinary, and bowel bother after robot-assisted prostatectomy (RALP), after high dose radiotherapy alone (RAD), or with adjuvant androgen deprivation therapy (RAD + ADT). We also studied the associations between psychosocial factors and post-treatment bother and the correlations between bother and function at the follow-up time points.
METHODS: A total of 462 patients (n = 150 RALP, n = 104 RAD, and n = 208 RAD + ADT) completed questionnaires at all time points (baseline, 3, 6, 12, and 24 months post-treatment). Our outcome measures were the proportion of patients who regained their baseline bother core (PBS-100) and the mean group scores on sexual, urinary, and bowel bother based on the UCLA-PCI questionnaire. Generalized estimating equation (GEE) identified the time points at which various variables were significantly associated with bother at 2 years. The time points at which the proportions of bothered patients became stable were defined.
RESULTS: The different treatment modalities provided distinctive patterns over time regarding urinary, sexual, and bowel bothers. RALP gave sexual and urinary bother, RAD + ADT patients reported bowel and sexual bother, while RAD patient suffered mainly from bowel bother. According to GEE, the bother scores at 3 or 6 months were significantly associated with the bother scores at 24 months for all groups. PBS-100 and stability of the recovered bother domains was reached at 3 to 6 months. Strong correlations were observed between function and bother for the urinary and bowel domains but not for the sexual domain. The associations between psychosocial factors and bother were weak.
CONCLUSIONS: Two years after treatment, RALP patients mainly reported sexual and urinary bother, while irradiated patients were bothered by bowel dysfunction. Sexual, urinary, and bowel bother reached stable proportions at 3 to 6 months post-treatment. Based on GEE, bother at 6 months was in general significantly associated with bother at 24 months.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bother; Prospective study; Prostate cancer; Prostatectomy; Radiotherapy

Mesh:

Substances:

Year:  2012        PMID: 22341412     DOI: 10.1016/j.urolonc.2011.12.020

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  10 in total

1.  Long-term quality of life outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with androgen deprivation.

Authors:  Hua-chun Luo; Li-ping Cheng; Hui-hua Cheng; Zhi-chao Fu; Shao-guang Liao; Dong-shi Li; Wen-fa Zheng; Gui-shan Lin; Jin-feng Zhu; Jian-feng Xu; Qin Yin; Qing-yang Yu
Journal:  Med Oncol       Date:  2014-05-22       Impact factor: 3.064

2.  Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.

Authors:  Kristine A Donovan; Brian D Gonzalez; Ashley M Nelson; Mayer N Fishman; Babu Zachariah; Paul B Jacobsen
Journal:  Psychooncology       Date:  2017-06-27       Impact factor: 3.894

3.  Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery.

Authors:  Sigrun Dahl; Jon Håvard Loge; Viktor Berge; Alv Andreas Dahl; Milada Cvancarova; Sophie Dorothea Fosså
Journal:  J Cancer Surviv       Date:  2014-09-13       Impact factor: 4.442

4.  Patient Reported Outcome Measure (PROM) of Quality of Life After Prostatectomy - Results from a 5-Year Study.

Authors:  Liselotte Jakobsson; Per Fransson
Journal:  Open Nurs J       Date:  2013-12-27

5.  Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial.

Authors:  Robert U Newton; Claus T Christophersen; Ciaran M Fairman; Nicolas H Hart; Dennis R Taaffe; David Broadhurst; Amanda Devine; Raphael Chee; Colin I Tang; Nigel Spry; Daniel A Galvão
Journal:  BMJ Open       Date:  2019-04-14       Impact factor: 2.692

6.  Association of Novel Androgen Receptor Axis-Targeted Therapies With Diarrhea in Patients With Prostate Cancer: A Bayesian Network Analysis.

Authors:  Xingyu Xiong; Hang Xu; Sheng Wang; Xinyang Liao; Xianyanling Yi; Kun Jin; Haoran Lei; Shengjiang Bai; Shi Qiu; Lu Yang
Journal:  Front Med (Lausanne)       Date:  2022-01-24

7.  High Neuroticism Is Related to More Overall Functional Problems and Lower Function Scores in Men Who Had Surgery for Non-Relapsing Prostate Cancer.

Authors:  Alv A Dahl; Sophie D Fosså
Journal:  Curr Oncol       Date:  2022-08-17       Impact factor: 3.109

8.  Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.

Authors:  Onita Bhattasali; Leonard N Chen; Jennifer Woo; Jee-Won Park; Joy S Kim; Rudy Moures; Thomas Yung; Siyuan Lei; Brian T Collins; Keith Kowalczyk; Simeng Suy; Anatoly Dritschilo; John H Lynch; Sean P Collins
Journal:  Radiat Oncol       Date:  2014-02-11       Impact factor: 3.481

9.  Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: study protocol for a pilot randomised controlled trial.

Authors:  Jane M Robertson; Gerard J Molloy; Prasad R Bollina; Daniel M Kelly; S Alan McNeill; Liz Forbat
Journal:  Trials       Date:  2014-05-24       Impact factor: 2.279

10.  Scandinavian Prostate Cancer Patients' Sexual Problems and Satisfaction With Their Sex Life Following Anti-Cancer Treatment.

Authors:  Gert Martin Hald; Mie Dahl Pind; Michael Borre; Theis Lange
Journal:  Sex Med       Date:  2018-07-13       Impact factor: 2.491

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.